Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Drug Delivery Meet-Pharma-2020

About Conference


 

With great pride and honour “International Congress on Drug Delivery” is announcing its global pharma event which is going to held in October 05-06, 2020 at Auckland, Newzealand. This Drug Delivery Meet-Pharma-2020 include a wide range of Keynote presentations, plenary talks, Symposia, Workshops, Exhibitions, Poster presentations and Career development programs. The main theme of our conference is "Novelties and Advancements in Drug Delivery and Formulation Techniques " this unique international conference will opportunity to reach the largest assemblage of participants from the Pharmaceutical community to gather and share their insights and convey recent developments in the field of generic drug research and current challenges and possibilities in modeling a new drug and breakthroughs in drug development, Generic drug safety, Novel trends and advanced strategies involving Formulation research. This is a global platform where ideas and discussion is driven by the participants and interaction with peers and others leads to fruitful outcomes.

Why to Attend???

Drug Delivery Meet-Pharma-2020 conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about formulations and drug delivery and its advances. This is your best opportunity to reach the largest assemblage of participants from Pharma research community that is from academia, drug delivery entities, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries.

Drug Delivery Meet-Pharma-2020 will discuss various disciplines involved in the drug formulation procedures and drug delivery technologies; it will educate health care researchers about design, operation, organizing, research computing, regulatory aspects and reporting of formulations. This conference conduct presentations, distribute information, meet with current and potential scientists, make a splash with new pharma research developments, and receive name recognition at this 2-days event. World renowned speakers and the most recent techniques, developments, the newest updates in formulations and drug delivery are hallmarks of this conference.

Who Should Attend and Who You’ll Meet:

Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of

Ø  CROs and CMOs

Ø  Pharma Research Sites

Ø  Pharma/Biotech and Medical Device industries

Ø  Hospitals, Associations

Target Audience:

Ø  Professors, Associate Professors, Assistant Professors

Ø  PhD Scholars

Ø  Graduates and Post Graduates

Ø  Directors, CEO’s of Organizations

Ø  Association, Association presidents and professionals

Ø  Noble laureates in Health Care and Medicine

Ø  Bio instruments Professionals

Ø  Bio-informatics Professionals

Ø  Software development companies

Ø  Research Institutes and members

Ø  Supply Chain companies

Ø  Manufacturing Companies

Ø  CRO and DATA management Companies

Ø  Training Institutes

Ø  Business Entrepreneur

Ø  Government healthcare departments, HTA’s and drug regulators

Ø  Digital health companies

Sessions and Tracks

Track 1: Drug Design & Development

Pharmaceutical Conferences 2020 describes drug design is the method of inventing innovative medications. Drug design and Drug formulation defines the design of molecules that are corresponding in shape and charge to the bio molecular target with which they interact and therefore will bind to it. Generally, the drug is a tiny organic molecule which triggers or slows down the activity of a bio-molecule such as a protein which repeatedly results in a medicinal benefit to the patient. Discovery of drugs and Drug formulation is challenging. Various medications are invented by chance observations, the scientific examination of other medicines or by finding out the side effects of some other drugs. A methodical technique is significant screening observations where important drug targets are tested with thousands of various compounds to observe, whether conversations occur. Basically, Drug Formulation and drug design involves drug design of small molecules that are harmonizing in shape and charge to the biomolecular target to which they act together and consequently will bind to it.

Related conferences: Drug Formulation Conferences Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences | Medicine Formulation Conferences Pre Formulation Conferences | Formulation Drug Conferences Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies Conferences | Public Health Conferences Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Europe & UK: European Association for Clinical Pharmacology and Therapeutics | Pharmaceutical Conferences 2020 | University of Vienna | Drug Delivery Conferences | Vienna University of Technology | Pharmacy Conferences 2020 | Imperial College LondonDrug Formulation Conferences | University College London(UCL) | Pharma Conferences 2020 | Universität Innsbruck | Pharmaceutical Conferences 2020 | Technische Universität Graz |  Drug Delivery ConferencesEuropean and Developing Countries Clinical Trials Partnership (EDCTP) | Pharmacy Conferences 2020University of Oxford | Drug Formulation ConferencesEuropean Federation of Biotechnology (EFB) | Pharma Conferences | University of Edinburgh | Pharmaceutical Conferences 2020 | Drug Delivery Conferences | University of Cambridge | Pharmacy Conferences 2020Pharmaceutical company | Pharma Conferences | International Federation of Pharmaceutical Manufacturers Associations (IFPMA) | Drug Formulation Conferences

Asia Pacific: International Pharmaceutical Federation (FIP) | Pharmaceutical Conferences 2020 | International Pharmaceutical Students' Federation (IPSF) |  Drug Delivery Conferences | Nanyang Technological University (NTU)Pharmacy Conferences 2020 | National University of Singapore (NUS) | Drug Formulation Conferences | The Hong Kong University of Science and Technology (HKUST) | Pharma Conferences 2020Korea Advanced Institute of Science and Technology(KAIST) | Pharmaceutical Conferences 2020 | University of Hong Kong (HKU), Drug Delivery ConferencesTsinghua University | Pharmaceutical Conferences 2020Drug Formulation ConferencesPeking University | Pharma Conferences 2020City University of Hong Kong | Pharmacy Conferences 2020 | The Chinese University of Hong Kong(CUHK) | Drug Delivery ConferencesNational Cheng Kung UniversityDrug Formulation ConferencesBandung Instituteof Technology (ITB)Pharma Conferences | Kyung Hee University | Pharmacy ConferencesNational Tsing Hua UniversityPharmaceutical Conferences 2020Drug Delivery Conferences

 Track 2: Novel Drug Delivery System

Identifying drug objectives plays critical roles in designing new drugs, drug formulations and combating illnesses. Unfortunately, our cutting-edge expertise about drug objectives is a long way from comprehensive. Screening drug goals within the lab is an luxurious and time-ingesting technique. In the past decade, the accumulation of diverse forms of study of technology associated statistics makes it viable to expand computational strategies to are expecting drug targets. Non-communicable diseases together with most cancers, atherosclerosis and diabetes are answerable for maximum important social and health ache as hundreds of thousands of people are loss of life each year. Out of which, atherosclerosis is the main purpose of deaths international. The lipid abnormality is one of the maximum crucial modifiable threat elements for atherosclerosis. Both genetic and environmental additives are associated with the improvement of atherosclerotic plaques. Immune and inflammatory mediators have a complicated position within the initiation and development of atherosclerosis. Understanding of a majority of these processes will assist to invent a range of new biomarkers and novel remedy modalities concentrated on diverse cellular occasions in acute and chronic inflammation which can be accountable for atherosclerosis. Several biochemical pathways, receptors and enzymes are involved in the development of atherosclerosis that would be possible targets for improving strategies for disease diagnosis and management.

Track 3: Computer Aided Drug Design (CADD)

The processes of designing a new drug by using bioinformatics implements have opened a new area of drug research and development. Computational techniques assist us in searching drug target and in Drug Formulation designing drug. Pharmaceutical Conferences 2020, Bioinformatics affects drug formulation and new drug design in the following drug design path. By using computational methods and the 3D structural information of the protein target, we are now able to scrutinize the detailed underlying molecular and atomic interactions involved in ligand: protein interactions and thus interpret experimental results in detail. The use of computers in drug formulation and drug discovery bears the additional advantage of delivering new drug candidates more rapidly and cost-efficiently. Computer-aided drug discovery has recently had important successes in drug formulation: new ligands have been predicted along with their receptor-bound structures and in several circumstances the achieved hit rates (ligands discovered per molecules tested) have been significantly greater than through experimental high-throughout screening. Strategies for CADD vary depending on the extent of structural and other information available regarding the target (enzyme/receptor) and the ligands.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Europe & UK: European Association for Clinical Pharmacology and Therapeutics | Pharmaceutical Conferences 2020 | University of Vienna | Drug Delivery Conferences | Vienna University of Technology | Pharmacy Conferences 2020 | Imperial College LondonDrug Formulation Conferences | University College London(UCL) | Pharma Conferences 2020 | Universität Innsbruck | Pharmaceutical Conferences 2020 | Technische Universität Graz |  Drug Delivery ConferencesEuropean and Developing Countries Clinical Trials Partnership (EDCTP) | Pharmacy Conferences 2020University of Oxford | Drug Formulation ConferencesEuropean Federation of Biotechnology (EFB) | Pharma Conferences | University of Edinburgh | Pharmaceutical Conferences 2020 | Drug Delivery Conferences | University of Cambridge | Pharmacy Conferences 2020Pharmaceutical company|PharmaConferences | International Federation of Pharmaceutical Manufacturers Associations (IFPMA) | Drug Formulation Conferences

Asia Pacific: International Pharmaceutical Federation (FIP) | Pharmaceutical Conferences 2020 | International Pharmaceutical Students' Federation (IPSF) |  Drug Delivery ConferencesNanyang Technological University (NTU)Pharmacy Conferences 2020 | National University of Singapore (NUS) | Drug Formulation Conferences | The Hong Kong University of Science and Technology (HKUST) | Pharma Conferences 2020https://drugdeliverymeet.pharmaceuticalconferences.com/registration.phpPharmaceutical Conferences 2020 | University of Hong Kong (HKU)Drug Delivery ConferencesTsinghua University | Pharmaceutical Conferences 2020Drug Formulation ConferencesPeking University | Pharma Conferences 2020City University of Hong Kong | Pharmacy Conferences 2020The Chinese University of Hong Kong(CUHK) | Drug Delivery ConferencesNational Cheng Kung UniversityDrug Formulation ConferencesBandung Instituteof Technology (ITB)Pharma Conferences | Kyung Hee University | Pharmacy Conferences | National Tsing Hua University | Pharmaceutical Conferences 2020 | Drug Delivery Conferences

Track 4:  Innovative Drug Discovery and Nanotechnology

Size reduction is a fundamental unit operation having critical packages in Pharmaceutical Sciences, Drug Formulations. It enables in enhancing solubility and bioavailability, decreasing toxicity, enhancing release and providing better drug components possibilities for capsules. In maximum of the instances, size discount is limited to micron size variety, for instance, numerous pharmaceutical dosage forms like powder, emulsion, suspension etc. Drugs in the nano meter size variety beautify overall performance in an expansion of dosage paperwork. Major benefits of nanosizing include (i) increased surface area, (ii) enhanced solubility, (iii) increased rate of dissolution, (iv) increased oral bioavailability, (v) more rapid onset of therapeutic action, (vi) less amount of dose required, (vii) decreased fed/fasted variability, and (viii) decreased patient-to-patient variability.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

 

Pharmaceutical nanotechnology has provided greater pleasant-tuned diagnosis and focused remedy of ailment at a molecular stage. Pharmaceutical nanotechnology is maximum progressive and quite specialized field, for you to revolutionize the pharmaceutical industry in close to destiny. Pharmaceutical nanotechnology provides progressive opportunities to combat against many sicknesses. It helps in detecting the antigen associated with illnesses consisting of cancer, diabetes mellitus, neurodegenerative illnesses, as well as detecting the microorganisms and viruses associated with infections. It is predicted that in subsequent 10 years market might be flooded with nanotechnology devised medicine.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Track 5: Pharmaceuticals Regulatory Affairs

Regulatory Affairs contributes essentially to the overall success of drug development, both at early pre-advertising and marketing tiers and at all times post-advertising and marketing. The pharmaceutical enterprise deals with more and more exciting drug candidates, all of which necessitate the involvement of the Regulatory Affairs’ branch. Regulatory Affairs specialists can play a key position in guiding drug formulations method in an increasingly more global surroundings. But additionally they play an essential operational function, for example, by way of thinking about the first-class approaches to comply with and allowing dependent interplay with regulatory authorities. Regulatory Affairs is driven by top science and for that reason nothing stays static.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Track 6: Business Opportunities in Drug Delivery

The global market for Business Development of Drug Delivery Technology in 2010 was $131.6 billion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016. The U.S constituted approximately 59% of the total drug delivery market in 2010 and was $78 billion. It is forecast to reach nearly $103 billion in 2016 at a CAGR of 4.7%. Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion and is expected to grow to $49 billion by 2016 at a CAGR of 5.6% in 2013, Drug Delivery Global market reached $150.3 billion, according to BCC research. This was an increase from $142 billion the previous year. Given its predicted annual growth the market represents a considerable business opportunity, which has been reflected in increasing number of drug delivery specialists. Consistent quality and competitive costs of product improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues, drug formulation, quality control, and business development Business opportunities in drug delivery.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Track 7: Bioequivalence Studies and Management

Bioequivalence research are achieved for both Early & past due Clinical Trial formulations, Drug formulations used in medical trials and stability studies, if exceptional Clinical trial formulations and to-be-advertised drug product on the subject of value and productivity metrics, it’s often said that what receives measured gets performed. Bioequivalence is determined primarily based on the bioavailability of the innovator remedy as opposed to the standard medication. The outline for bioequivalence have a look at includes the business enterprise of check and reference gadgets on two activities to volunteer subjects, with each corporation isolated by a washout period. This Study involves parameters on (Cmax) and (AUC), Statistical evaluation.

Assessment of the bioequivalence of generic versions of certain reference drugs is complicated by the presence of endogenous levels of said compounds which cannot be distinguished from externally derived compound levels following drug administration. If unaccounted for, the presence of endogenous compound biases towards equivalence in bioequivalence studies of these drugs. Bioequivalence assessments may be complicated further as disposition of the exogenous analogue can be subject to various endogenous processes resulting in nonlinear pharmacokinetics. To overcome these inherent biases a number of different strategies have been employed.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Track 8: Chemical and Pharmaceutical Engineering

Pharmaceutical engineering is a branch of pharmaceutical technology and science that involves improvement and production of products, techniques, and additives within the pharmaceuticals industry (i.e. drugs & biologics). While developing pharmaceutical merchandise includes many interrelated disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologists, pharmacists, chemical engineers, biomedical engineers, etc.), the precise subfield of "pharmaceutical engineering" has most effective emerged recently as a divergent engineering discipline. This now brings the trouble-solving standards and quantitative education of engineering to complement the opposite scientific fields already worried in drug formulation.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Track 9: Pharmaceutical Research and Development

Development of a new medicine takes nearly 10-15 years and on average and costs an average of $2.6 billion. In discovery procedure comprises the initial stages of research, which are intended to recognize an investigational drug and perform primary tests in the lab. This first stage of the process takes   three to six years. By the end, investigators hope to identify a capable drug aspirant to further study in the lab and in animal models, and then in people. These developments offer great ability, but also add complexity to the R&D process. In order to ensure the safety and efficacy of personalized therapies that are used along with diagnostics, clinical trial protocols must be improved and increased.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Track 10: Pharmaceutical Formulations: Types and Novelties

Pharmaceutical formulations vary on the route of administration. Eternal formulations prolong the action of duration of drug. Eternal formulation includes tablet, capsule and sustained release dosage forms. Parenteral formulation impacts both the safety and efficacy of drug. The effect of the dosage form depends on the route of administration. A low medication load may cause homogeneity issues. A high medication load may posture stream issues or require extensive containers if the compound has a low mass thickness.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Track 11: Challenges in Drug Administration

Medication are used to prevent and illness. Depending upon their site of action and safety and efficacy of drug drugs can be administered through a variety like oral, parenteral, Transdermal, Intradermal etc.. While administering a drug we have to consider the possible side effects and dangerous reactions also. The Dosage of the drug has to be carefully determined. In US, it has been estimated that 80 per cent of active ingredients and 40 per cent of the final drug products are imported. Medicine slant and bolster significance have been surveyed by taking a gander at the self-association of no less than two drugs open under various trial conditions, including choice procedure, dynamic extent fortress timetables, and chain stronghold logbooks.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Track 12: Wearable Drug Delivery

These are changing the world of drug delivery and preventing the patients from continuous bulk ambulatory devices. Wearable drug delivery device delivers insulin to the wearer.  These are developed for dosing a range of drugs such as hormones, analgesics, anti-hypertensives. Large doses 5ml to 50 ml can be comfortably be self-administered by the patient at home by using the Wearable Drug Delivery devices. The life cycle of the product can also be increases. Wearable technology speeds the Formulation and development.

The annual growth rate is expected to reach USD $824 bn by 2025. The size of the market opportunity for LVI devices alone has been estimated at $8.1 billion by 2025, with over 50% of this driven by devices to deliver drugs for cancer and related conditions.

Related conferences: Drug Formulation Conferences | Pharmaceutical Formulation Conferences | Dosage Form Conferences | Formulation and Development Conferences Medicine Formulation Conferences | Pre Formulation Conferences | Formulation Drug Conferences | Tablet Formulation Conferences Regulatory Affairs Conferences | Formulation Development Conferences | Formulation Pharmaceutical Conferences | Drug Development Process Conferences | Drug Delivery Conferences | Bioavailability Conferences Drug Formulation Companies ConferencesPublic Health Conferences | Parenteral Formulation Development Conferences | Oral Bioavailability Conferences

Related Pharma Societies:

USA: American Association of Colleges of Pharmacy(AACP) | Pharmaceutical Conferences 2020 | University of North Carolina--Chapel Hill | Drug Delivery Conferences | American Pharmacists Association(APhA) | Pharmacy Conferences 2020 | University of California--San Francisco | Pharma Conferences 2020 | American Society for Pharmacy Law | Drug Formulation Conferences | American Society of Consultant Pharmacists | Pharmaceutical Conferences 2020 | American Society of Health-System Pharmacists | Drug Delivery Conferences |  Drug Formulation Society for Clinical Trials | Pharmacy Conferences 2020 | The Society of Clinical Research Associates | Pharma Conferences 2020Professional Compounding Centers of America | Drug Formulation Conferences | American Association of Pharmaceutical Scientists | Pharmaceutical Conferences 2020 |  College of Psychiatric and Neurologic Pharmacists(CPNP) | Drug Delivery Conferences | Pharmaceutical Research and Manufacturers of America |  Pharmacy Conferences 2020 | University of Minnesota | Pharma Conferences 2020 | University of Michigan--Ann Arbor | Drug Formulation Conferences

Market Analysis

Drug Delivery Meet-Pharma-2020

Pharmaceutics & Drug Delivery Market Research:

Global Pharmaceutical Market 2019 Industry Research Report is a professional and in-depth study on the current state of the Global Pharmaceutical industry. This report studies Global Pharmaceutical in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India with production, revenue, consumption, import and export in these regions, from 2014 to 2019, and forecast to 2025.

The Global Pharmaceutical market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Pharmaceutical market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The global pharmaceuticals market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, according to a recent pharma market research report by The Business Research Company.

This is an accelerated pace compared to 5.2% for the years before 2017 but is slower than the other two large healthcare segments, medical equipment and healthcare services. Healthcare as a whole is growing at over 7% year on year.

The report also focuses on global major leading industry players of Global Pharmaceutical market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Global Pharmaceutical market development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions offered.

Novel Drug Delivery Market:

Novel Drug Delivery Systems Market Report provides a relevant source of perceptive data for investors. Novel Drug Delivery Systems Market Report also examines global Novel Drug Delivery Systems Industry growth analysis, the past and innovative cost, demand and supply information, and revenue.

The global Novel Drug Delivery Systems Market analyses and researches the Novel Drug Delivery Systems development status and forecast in the United States, EU, Japan, China, India, and Southeast Asia. This report focuses on the top players in the global market.

North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%.

The Global Novel Drug Delivery Systems market is valued at 26500 million US$ in 2018 and will reach 31100 million US$ by the end of 2025, growing at a CAGR of 2.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of The Novel Drug Delivery Systems market based on company, product type, end user and key regions.

Key players having presence in the global nanotechnology drug delivery market are AbbVie, Inc., Amgen, Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., and Novartis International AG, among others.

Scope & Importance:

Pharmaceutical marketing is the last element of an information continuum, where research concepts are transformed into practical therapeutic tools and where information is progressively layered and made more useful to the health care system. Thus, transfer of information to physicians through marketing is a crucial element of pharmaceutical innovation. By providing an informed choice of carefully characterized agents, marketing assists physicians in matching drug therapy to individual patient needs. Pharmaceutical marketing is presently the most organized and comprehensive information system for updating physicians about the availability, safety, efficacy, hazards, and techniques of using medicines. The costs of pharmaceutical marketing are substantial, but they are typical of high-technology industries that must communicate important and complex information to sophisticated users. These costs are offset by savings resulting from proper use of medicines and from lower drug costs owing to price competition.

Advanced Drug Delivery Systems

The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. • The North American market should grow from nearly $75.7 billion in 2015 to $93.4 billion by 2020, a CAGR of 4.3%. • The European market should grow from roughly $57.3 billion in 2015 to nearly $72.1 billion by 2020, a CAGR of 4.7%.

Antibiotics

• The global systemic antibiotics market should reach nearly $44.7 billion in 2020 from nearly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020.

• The beta-lactams market should reach over $22.0 billion by 2020 from over $20.6 billion in 2015, a CAGR of 1.3% from 2015 to 2020.

• The other antibiotic classes market should reach over $10.6 billion in 2020 from nearly $8.3 billion in 2015, a CAGR of 5.0% from 2015 to 2020.

Excipients in Pharmaceuticals

• The global excipients market should reach nearly $6.9 billion by 2020 from over $6.2 billion in 2015, a compound annual growth rate (CAGR) of 1.9% from 2015 to 2020.

• The organic excipients market should reach $6.3 billion by 2020 from nearly $5.8 billion in 2015, a CAGR of 1.7% from 2015 to 2020.

• The inorganic excipients market should reach $433.7 million by 2020 from $351.9 million in 2015, a CAGR of 4.3% from 2015 to 2020.

Ophthalmic Therapeutic Drugs

• The global ophthalmic therapeutic drug market was valued at $12.3 billion in 2014. This market is expected to reach $19 billion by 2020, with a compound annual growth rate (CAGR) of 9.1% from 2014 to 2020. • The global age-related macular degeneration (AMD) market is expected to grow to nearly $7.9 billion by 2019 from nearly $5.4 billion in 2014, a CAGR of 7.8% from 2014 to 2020. • The global glaucoma therapeutic market generated revenue of $3.8 billion in 2014, and by 2020 this segment is expected to generate $6.4 billion, with a CAGR of 11.1% from 2014 to 2020.

Target Audience:

  • Drug Delivery Technology Manufacturers
  • Public and Private Physicians
  • Healthcare Institutions (Medical Data Centers)
  • Research & Clinical Laboratories
  • Distributors and Suppliers of Drug Delivery Technologies
  • Health Insurance Payers
  • Market Research and Consulting Firms

Pharmaceutical Companies:

Novartis

Roche

Johnson & Johnson

Merck

Sanofi

Pfizer

Bayer

Eli lily

Amgen

AstraZeneca

AbbVie

Celgene

GlaxoSmithKline

Boehringer Ingelheim

Bristol-Myers Squibb

Takeda Pharmaceutical

Otsuka

Novo Nordisk

Gilead Sciences

Biogen Idec

Allergen

Actavis

Shire

Mylan

Actelion

Ipsen

Novozymes

Zoetis

*Source: BCC Research & Transparency Market Research

Past Conference Report

The 2nd International Conference on Pharmaceutical Chemistry hosted by the Conference Series LLC Ltd was held during October 02-04, 2017 at TRYP Barcelona Aero Puerto, Barcelona, Spain based on the theme Recent Trends and Advancements in the fields of Pharma and Chemistry ". Benevolent response and active participation were received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from the area of Pharmaceutical Chemistry, Chemistry and Analytical science, who made this event a grand success.

Conference Series LLC Ltd expresses its gratitude to the conference Moderator, namely Dr. Matthew D. Lloyd from University of Bath, UK and  Dr. Sundaram Singh from Indian Institute of Technology (BHU), India for taking up the responsibility to coordinate during the sessions. We are indebted to your support. Similarly, we also extend our appreciation towards our Poster judges namely, Dr. Catherine Guillou, University of Paris-Saclay, France and Dr. Xianglin Shi, Chemical Process R&D, Biogen Idec, USA.

Conference Series LLC Ltd would like to convey warm gratitude to all the Honorable guests and Keynote Speakers of Pharmaceutical Chemistry 2017:

Catherine Guillou, University of Paris-Saclay, France

Xianglin Shi, Chemical Process R&D, Biogen Idec, USA

Mark McLaughlin, Merck Sharp & Dohme, USA

Gervais Bérubé, Université du Québec à Trois-Rivières, Canada

Larisa Klapshina, Nizhny Novgorod State University, Russia

Fabio Marinelli, University of L’Aquila, Italy

Alexander V. Sirotkin, Constantine the Philosopher University, Slovakia

Conference Series LLC Ltd offers its heartfelt appreciation to organizations such as our esteemed Media Partners, Exhibitors, and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. It also took the privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Co-chairs who supported this event.

Best Poster Awards Winners:

  • Nikolay S. Zimnitskiy, Ural Federal University, Russia
  • Mohammed Alqarni, De Montfort University, UK
  • Shih-Chieh Yen, Development Center for Biotechnology,  Institute of Pharmaceutics, Taiwan

With the grand success of Pharmaceutical Chemistry 2017, Conference Series is proud to announce the International Congress on Drug Delivery" to be held during October 05-06, 2020 Auckland, Newzealand.

Let us meet again @ Drug Delivery Meet-Pharma-2020

To Collaborate Scientific Professionals around the World

Conference Date October 05-06, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Research & Reviews in Pharmacy and Pharmaceutical Sciences International Journal of Drug Development and Research Journal of Pharmaceutical Sciences & Emerging Drugs

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by